Nektar Therapeutics (NKTR) Liabilities from Discontinued Operations (2024)
Nektar Therapeutics (NKTR) recorded quarterly Liabilities from Discontinued Operations of 5125000.0 in Q3 2024.
Nektar Therapeutics (NKTR) Liabilities from Discontinued Operations (2024) Analysis & Trends
Nektar Therapeutics' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 5125000.0 for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 5.13 Mn |
| Sep 30, 2024 | 5.13 Mn |